Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis

BACKGROUND: The aim of the study was to explore the efficacy and safety of immune checkpoint inhibitor (ICI) rechallenge in patients with non‐small cell lung cancer (NSCLC). METHODS: Studies that enrolled NSCLC patients treated with two lines of ICIs were included using four databases. The initial l...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yu, Tao, Yunxia, Chen, Haizhu, Zhou, Yu, Tang, Le, Liu, Chenwei, Hu, Xingsheng, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481143/
https://www.ncbi.nlm.nih.gov/pubmed/37551891
http://dx.doi.org/10.1111/1759-7714.15063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481143/
https://www.ncbi.nlm.nih.gov/pubmed/37551891
http://dx.doi.org/10.1111/1759-7714.15063

Ejemplares similares